Bomfim, I L
Lamb, F
Fink, K
Szakács, A
Silveira, A
Franzén, L
Azhary, V
Maeurer, M
Feltelius, N
Darin, N
Hallböök, T
Arnheim-Dahlström, L
Kockum, I
Olsson, T
Article History
Received: 3 October 2016
Revised: 6 December 2016
Accepted: 7 December 2016
First Online: 23 March 2017
Competing interests
: LAD has obtained funding from MDS Sanofi Pasteur and from GlaxoSmithKline for other studies than this one. TO has received unrestricted multiple sclerosis research grants from Biogen, AstraZeneca, Novartis and Genzyme. IK has received unrestricted multiple sclerosis research grants from AstraZeneca. The other authors declare no conflict of interest.